Centre Hospitalier Universitaire de Nîmes
Nîmes, Occitanie, 30900, France
NCT Number: NCT07207629
This study investigates the impact of blood donation on transthoracic echocardiography (TTE) parameters in healthy volunteers, aiming to enhance the understanding of hemodynamic changes associated with mild blood loss and assess non-invasive monitoring techniques for early hemorrhage detection. Conducted as a prospective, interventional study with minimal risk, this research is designed to simulate a controlled hemorrhage in a civilian setting, using voluntary blood donation as a model to study the physiological effects of blood loss of approximately 6 mL/kg.
Rationale and Background Hemorrhagic shock is a leading cause of preventable death in trauma patients, particularly among younger populations. The ability to rapidly detect and quantify blood loss is crucial in trauma management, as delayed or excessive resuscitation can lead to adverse outcomes, including multi-organ failure and coagulopathy. Traditional methods of monitoring blood volume and cardiac output, such as invasive catheterization or imaging techniques like CT scans, may not be feasible or practical in prehospital settings. TTE, particularly the measurement of the aortic time-velocity integral (TVI) using Doppler echocardiography, presents a non-invasive and potentially valuable tool for assessing cardiac output and detecting early hemodynamic changes due to blood loss.
Primary Objective The primary objective of this study is to evaluate whether the aortic TVI decreases by at least 10% following a controlled blood volume reduction during blood donation. This decrease in TVI could serve as a reliable marker of reduced cardiac output and might allow clinicians to detect mild to moderate blood loss in trauma patients non-invasively.
Secondary Objectives
The study also aims to examine additional echocardiographic parameters that may indicate changes in hemodynamic status following blood loss. Secondary objectives include measuring changes in:
Shock index (SI), calculated as the ratio of heart rate to systolic blood pressure, a parameter often associated with hypovolemia.
E-wave and e'-wave velocities, which reflect left ventricular filling pressures and diastolic function.
Ratios of E/e' and E/A, which are indicative of left ventricular diastolic function and filling pressures.
Global longitudinal strain of the left ventricle (GLS), which represents myocardial contractility.
Methods Healthy adult volunteers meeting eligibility criteria for blood donation are recruited from local blood donation centers. Participants undergo baseline TTE to measure the aortic TVI, E-wave, e'-wave, and other relevant parameters before donation. Following a blood donation procedure of approximately 450 mL (representing a 6 mL/kg blood loss for the average volunteer), TTE is repeated immediately after donation and then 15 minutes post-donation to capture any transient changes in cardiac output and ventricular function. Volunteers receive structured hydration and are observed for any adverse events.
Outcome Measures The primary outcome measure is a decrease of at least 10% in aortic TVI from baseline immediately following blood donation, which would confirm the sensitivity of TTE to detect mild hypovolemia. Secondary outcome measures include changes in the shock index, variations in Doppler-derived E and e' waves, and the E/e' and E/A ratios, assessed immediately and 15 minutes post-donation. The study will also monitor the global longitudinal strain (GLS) as an additional measure of left ventricular performance.
Statistical Analysis The required sample size was calculated to detect a 10% decrease in TVI with 90% power at a 5% significance level, resulting in a target enrollment of 66 participants. Descriptive statistics will be used for continuous variables, expressed as mean ± standard deviation or median and interquartile range as appropriate. Paired t-tests or Wilcoxon signed-rank tests will assess changes in parameters before and after blood donation. Each participant's response will be classified as positive if a decrease of at least 10% in TVI is observed, or negative if the decrease is below this threshold.
Potential Impact If successful, this study could validate the use of TTE-derived parameters, such as aortic TVI and shock index, as non-invasive markers for early detection of blood loss in trauma patients. By providing real-time insight into hemodynamic changes, this approach could improve decision-making in prehospital and emergency settings, allowing clinicians to tailor resuscitation strategies based on the actual volume of blood loss. This could reduce the risks associated with both under-resuscitation and over-resuscitation, ultimately improving patient outcomes.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Nîmes, Occitanie, 30900, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy adult volunteers eligible for blood donation according to French Blood Establishment (EFS) standards.
Age between 18 and 40 years. Participants who have provided written, informed consent. Affiliated with or a beneficiary of a social security system.
Exclusion criteria
Obesity (BMI > 30 kg/m²) or underweight (BMI < 18 kg/m²). Body weight over 96 kg. History of valvular heart disease, ischemic heart disease, or congestive heart failure.
Known allergy to ultrasound gel. Current medications that could affect hemodynamic response to blood loss (e.g., antihypertensives, antiepileptics, NSAIDs).
Participation in other human research studies defined as Category 1. Subjects under legal protection, including guardianship or curatorship. Pregnant, lactating, or breastfeeding women. Conditions that contraindicate blood donation.
TTE will be performed before, just after and 15 minutes after a blood donation, with measurement of aortic VTI, E wave, e' wave, A wave and left ventricle global longitudinal strain
Time frame: At two time points: prior to blood donation (baseline) and at completion of donation (at catheter withdrawal) - at day 0, 15 minutes after baseline
measured by apical 5 cavity TTE
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline ; and 15 minutes after blood donation (at day 0, 30 minutes after baseline)
heart rate divided per systolic blood pressure
Time frame: At three time points: prior to blood donation (baseline) , at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline ; and 15 minutes after blood donation at day 0, 30 minutes after baseline
measured on 4 cavity apical TTE
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
measured on 4 cavity apical TTE
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
measured on 4 cavity apical TTE
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
calculation of the ratio of E and A measures
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
calculation of the ratio of E and e' measures
Time frame: At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
Time frame: at day 0, 15 minutes after baseline and 15 minutes after blood donation, at day 0, 30 minutes after baseline
Centre Hospitalier Universitaire de Nīmes
Other
Acronym: EDoS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05958342
Diabetes Insipidus, Endocrine System Diseases
Tucson, Arizona, United States
View Trial DetailsNCT04667468
Hemorrhage, Pathologic Processes
Los Angeles, California, United States
View Trial DetailsNCT06725602
Disease Attributes, Emergencies
Ribeirão Preto, São Paulo, Brazil
View Trial DetailsNCT06742801
Digestive System Diseases, GI Bleed
Phoenix, Arizona, United States
View Trial Details